Unexplained Left Ventricular Hypertrophy Diagnosed as a Cardiac Variant of Late-Onset Fabry Disease: A Case Report

Author:

Zhao Maomao1ORCID,Niu Xiaowei1,Bai Lu1,Zhang Yinchang2ORCID,Wang Ting1,Wa Yongling1,Wei Junchu1,Dong Kang1,Zhang Xin1,Bai Ming1

Affiliation:

1. Department of Cardiology, First Hospital of Lanzhou University, Lanzhou University, Lanzhou 730030, China

2. Department of Cardiac Surgery, Lanzhou University Second Hospital, Lanzhou University, Lanzhou 730030, China

Abstract

The cardiac variant of Fabry disease (FD) has high rates of missed diagnosis and misdiagnosis due to the lack of systemic symptoms. Here, we report a case of a 68-year-old female with delayed-onset FD presenting as concentric left ventricular hypertrophy (LVH) with right bundle branch block, atrial fibrillation, and diastolic dysfunction, which was first presented with coronary artery spasm. Early cardiac-specific signs are crucial for diagnosing this disease due to the lack of extracardiac indications and the late onset of symptoms. This case raises a new red flag that patients with unexplained LVH and its atypical electrocardiographic (ECG) manifestations accompanied by diastolic dysfunction should be considered for FD. We also recommend further refinement of examinations associated with Fabry disease, which will contribute to the early diagnosis and treatment of the disease.

Funder

Science and Technology Program of Gansu Province

Scientific Research Project of Health Industry of Gansu Province

Science and Technology Planning Project of Lanzhou City

Youth Doctoral Fund Project of the Department of Education in Gansu Province

Special Fund for Civil-Military Integration Development of Gansu Province

Foundation for Scientific Research of the First Hospital of Lanzhou University

Publisher

MDPI AG

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Reference9 articles.

1. Fabry Disease Revisited: Management and Treatment Recommendations for Adult Patients;Ortiz;Mol. Genet. Metab.,2018

2. A Detailed Pathologic Examination of Heart Tissue from Three Older Patients with Anderson-Fabry Disease on Enzyme Replacement Therapy;Sheppard;Cardiovasc. Pathol. Off. J. Soc. Cardiovasc. Pathol.,2010

3. Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week;Pieroni;J. Am. Coll. Cardiol.,2021

4. Precision Medicine in Fabry Disease;Lenders;Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Ren. Assoc.,2021

5. Long-Term Outcome of Enzyme-Replacement Therapy in Advanced Fabry Disease: Evidence for Disease Progression towards Serious Complications;Weidemann;J. Intern. Med.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3